piperacillin has been researched along with fosfomycin in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.00) | 18.7374 |
1990's | 5 (20.00) | 18.2507 |
2000's | 9 (36.00) | 29.6817 |
2010's | 6 (24.00) | 24.3611 |
2020's | 1 (4.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Brown-Driver, V; Finn, J; Haselbeck, RJ; Hilgers, MT; Kedar, GC; Reyes, DR; Shaw, KJ; Stidham, MA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cars, O; Löwdin, E; Melhus, A; Tängdén, T | 1 |
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Capri, S; Del Bono, GP; Dellamano, R | 1 |
Kuzui, H; Murakami, T; Nishino, T; Obana, Y | 1 |
Kawamura, M; Kuyama, T; Miyamoto, M; Sudo, T | 1 |
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
Hayashi, T; Katahira, J; Kitayama, R; Kumada, T; Kumano, K; Muratani, T; Saikawa, I; Shimizu, K; Watanabe, Y; Yasuda, T | 1 |
Hayashi, T; Katahira, J; Kitayama, R; Kumada, T; Kumano, K; Saikawa, I; Shimizu, K; Watanabe, Y; Yasuda, T | 1 |
Haag, R | 1 |
Kanno, H; Takahashi, K | 1 |
Georgieff, M; Konrad, F; Neumeister, B; Rommel, H; Wagner, R | 1 |
Araake, M; Hara, T; Tsuruoka, T; Watabe, H | 1 |
Lin, CT; Peng, HL | 1 |
Ammann, RA; Bode, U; Engelhart, S; Fleischhack, G; Gröger, N; Hasan, C; Kramer, MH; Simon, A; Wilkesmann, A; Wiszniewsky, G | 1 |
Chakraborty, T; Fritzenwanker, M; Herold, S; Imirzalioglu, C; Wagenlehner, FM; Zimmer, KP | 1 |
Harris, PNA | 1 |
Chusri, S; Ontong, JC; Ozioma, NF; Voravuthikunchai, SP | 1 |
2 review(s) available for piperacillin and fosfomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment Options for Carbapenem- Resistant Gram-Negative Infections.
Topics: Aminoglycosides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Therapy, Combination; Escherichia coli; Fluoroquinolones; Fosfomycin; Germany; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Tigecycline | 2018 |
23 other study(ies) available for piperacillin and fosfomycin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.
Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Proteins; Drug Resistance, Bacterial; Fosfomycin; Inhibitory Concentration 50; Microbial Sensitivity Tests; RNA, Antisense | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Cost-effectiveness comparison of single and multiple-dose antibiotic treatment of lower uncomplicated urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosfomycin; Humans; Piperacillin; Time Factors; Tromethamine; Urinary Tract Infections | 1992 |
[Bacterial combination effect between carumonam and eight other antibiotics].
Topics: Animals; Aztreonam; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Female; Fosfomycin; Gentamicins; Mice; Piperacillin; Proteus vulgaris; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections | 1990 |
Assessment of antimicrobial penetration into the pancreatic juice in dogs.
Topics: Animals; Anti-Bacterial Agents; Ceftizoxime; Dogs; Female; Fosfomycin; Male; Netilmicin; Pancreatic Juice; Piperacillin | 1990 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of pipera
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftazidime; Doxycycline; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Fosfomycin; Moxalactam; Piperacillin; Sulbactam | 1990 |
Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.
Topics: Animals; Blood Urea Nitrogen; Cisplatin; Fosfomycin; Kidney; Kidney Diseases; Leukemia L1210; Male; Piperacillin; Platinum; Rats; Rats, Inbred F344 | 1989 |
Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals.
Topics: Animals; Cephaloridine; Cephalothin; Fosfomycin; Gentamicins; Kidney Cortex; Kidney Diseases; Kidney Medulla; Male; Piperacillin; Rabbits; Rats; Rats, Inbred Strains | 1988 |
Fosfomycin, piperacillin, azlocillin. Correlation between therapeutic response of mice infected with Pseudomonas aeruginosa and in vitro data.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; Fosfomycin; Kinetics; Mice; Microbial Sensitivity Tests; Models, Biological; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1984 |
Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefsulodin; Drug Synergism; Fosfomycin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1984 |
Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Metronidazole; Middle Aged; Netilmicin; Piperacillin; Respiration, Artificial; Staphylococcal Infections; Teicoplanin | 1993 |
[Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Cefmetazole; Cefotiam; Coagulase; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fosfomycin; Methicillin; Piperacillin; Staphylococcus; Staphylococcus aureus | 2003 |
Regulation of the homologous two-component systems KvgAS and KvhAS in Klebsiella pneumoniae CG43.
Topics: Amino Acid Sequence; Bacterial Proteins; Carbenicillin; Cephalothin; Electrophoretic Mobility Shift Assay; Fosfomycin; Gene Deletion; Gene Expression Regulation, Bacterial; Histidine Kinase; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Piperacillin; Promoter Regions, Genetic; Protein Kinases; Sigma Factor; Signal Transduction; Transcription Factors | 2006 |
Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Fosfomycin; Glycopeptides; Humans; Infant; Length of Stay; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Teicoplanin; Treatment Outcome | 2006 |
By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?
Topics: Fosfomycin; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2019 |
Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Fosfomycin; Klebsiella pneumoniae; Piperacillin; Tetracyclines | 2021 |